Biomarkers for Bronchopulmonary Dysplasia in the Preterm Infant

Autores
Rivera, Lidys; Siddaiah, Roopa; Oji Mmuo, Christiana; Silveyra, Gabriela Romina; Silveyra, Patricia
Año de publicación
2016
Idioma
inglés
Tipo de recurso
artículo
Estado
versión publicada
Descripción
Bronchopulmonary dysplasia (BPD) is a chronic inflammatory lung disease of very-low-birth-weight (VLBW) preterm infants, associated with arrested lung development and a need for supplemental oxygen. Over the past few decades, the incidence of BPD has significantly raised as a result of improved survival of VLBW infants requiring mechanical ventilation. While early disease detection is critical to prevent chronic lung remodeling and complications later in life, BPD is often difficult to diagnose and prevent due to the lack of good biomarkers for identification of infants at risk, and overlapping symptoms with other diseases, such as pulmonary hypertension (PH). Due to the current lack of effective treatment available for BPD and PH, research is currently focused on primary prevention strategies, and identification of biomarkers for early diagnosis, that could also represent potential therapeutic targets. In addition, novel histopathological, biochemical, and molecular factors have been identified in the lung tissue and in biological fluids of BPD and PH patients that could associate with the disease phenotype. In this review, we provide an overview of biomarkers for pediatric BPD and PH that have been identified in clinical studies using various biological fluids. We also present a brief summary of the information available on current strategies and guidelines to prevent and diagnose BPD and PH, as well as their pathophysiology, risk factors, and experimental therapies currently available.
Fil: Rivera, Lidys. State University of Pennsylvania; Estados Unidos
Fil: Siddaiah, Roopa. State University of Pennsylvania; Estados Unidos
Fil: Oji Mmuo, Christiana. State University of Pennsylvania; Estados Unidos
Fil: Silveyra, Gabriela Romina. State University of Pennsylvania; Estados Unidos. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Ciudad Universitaria. Instituto de Biodiversidad y Biología Experimental y Aplicada. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales. Instituto de Biodiversidad y Biología Experimental y Aplicada; Argentina
Fil: Silveyra, Patricia. State University of Pennsylvania; Estados Unidos. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Biología y Medicina Experimental. Fundación de Instituto de Biología y Medicina Experimental. Instituto de Biología y Medicina Experimental; Argentina
Materia
Bronchopulmonary Dysplasia
Pulmonary hypertension
Preterm infants
Biomarkers
Nivel de accesibilidad
acceso abierto
Condiciones de uso
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
Repositorio
CONICET Digital (CONICET)
Institución
Consejo Nacional de Investigaciones Científicas y Técnicas
OAI Identificador
oai:ri.conicet.gov.ar:11336/60769

id CONICETDig_3d8376e53cfdc3c1f84045f2abbee53a
oai_identifier_str oai:ri.conicet.gov.ar:11336/60769
network_acronym_str CONICETDig
repository_id_str 3498
network_name_str CONICET Digital (CONICET)
spelling Biomarkers for Bronchopulmonary Dysplasia in the Preterm InfantRivera, LidysSiddaiah, RoopaOji Mmuo, ChristianaSilveyra, Gabriela RominaSilveyra, PatriciaBronchopulmonary DysplasiaPulmonary hypertensionPreterm infantsBiomarkershttps://purl.org/becyt/ford/1.6https://purl.org/becyt/ford/1Bronchopulmonary dysplasia (BPD) is a chronic inflammatory lung disease of very-low-birth-weight (VLBW) preterm infants, associated with arrested lung development and a need for supplemental oxygen. Over the past few decades, the incidence of BPD has significantly raised as a result of improved survival of VLBW infants requiring mechanical ventilation. While early disease detection is critical to prevent chronic lung remodeling and complications later in life, BPD is often difficult to diagnose and prevent due to the lack of good biomarkers for identification of infants at risk, and overlapping symptoms with other diseases, such as pulmonary hypertension (PH). Due to the current lack of effective treatment available for BPD and PH, research is currently focused on primary prevention strategies, and identification of biomarkers for early diagnosis, that could also represent potential therapeutic targets. In addition, novel histopathological, biochemical, and molecular factors have been identified in the lung tissue and in biological fluids of BPD and PH patients that could associate with the disease phenotype. In this review, we provide an overview of biomarkers for pediatric BPD and PH that have been identified in clinical studies using various biological fluids. We also present a brief summary of the information available on current strategies and guidelines to prevent and diagnose BPD and PH, as well as their pathophysiology, risk factors, and experimental therapies currently available.Fil: Rivera, Lidys. State University of Pennsylvania; Estados UnidosFil: Siddaiah, Roopa. State University of Pennsylvania; Estados UnidosFil: Oji Mmuo, Christiana. State University of Pennsylvania; Estados UnidosFil: Silveyra, Gabriela Romina. State University of Pennsylvania; Estados Unidos. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Ciudad Universitaria. Instituto de Biodiversidad y Biología Experimental y Aplicada. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales. Instituto de Biodiversidad y Biología Experimental y Aplicada; ArgentinaFil: Silveyra, Patricia. State University of Pennsylvania; Estados Unidos. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Biología y Medicina Experimental. Fundación de Instituto de Biología y Medicina Experimental. Instituto de Biología y Medicina Experimental; ArgentinaFrontiers Media S.A.2016-03info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfapplication/pdfhttp://hdl.handle.net/11336/60769Rivera, Lidys; Siddaiah, Roopa; Oji Mmuo, Christiana; Silveyra, Gabriela Romina; Silveyra, Patricia; Biomarkers for Bronchopulmonary Dysplasia in the Preterm Infant; Frontiers Media S.A.; Frontiers in Pediatrics; 4; 3-2016; 1-172296-23602296-2360CONICET DigitalCONICETenginfo:eu-repo/semantics/altIdentifier/url/https://www.frontiersin.org/articles/10.3389/fped.2016.00033/fullinfo:eu-repo/semantics/altIdentifier/doi/10.3389/fped.2016.00033info:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by-nc-sa/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2025-09-29T10:08:22Zoai:ri.conicet.gov.ar:11336/60769instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982025-09-29 10:08:22.458CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse
dc.title.none.fl_str_mv Biomarkers for Bronchopulmonary Dysplasia in the Preterm Infant
title Biomarkers for Bronchopulmonary Dysplasia in the Preterm Infant
spellingShingle Biomarkers for Bronchopulmonary Dysplasia in the Preterm Infant
Rivera, Lidys
Bronchopulmonary Dysplasia
Pulmonary hypertension
Preterm infants
Biomarkers
title_short Biomarkers for Bronchopulmonary Dysplasia in the Preterm Infant
title_full Biomarkers for Bronchopulmonary Dysplasia in the Preterm Infant
title_fullStr Biomarkers for Bronchopulmonary Dysplasia in the Preterm Infant
title_full_unstemmed Biomarkers for Bronchopulmonary Dysplasia in the Preterm Infant
title_sort Biomarkers for Bronchopulmonary Dysplasia in the Preterm Infant
dc.creator.none.fl_str_mv Rivera, Lidys
Siddaiah, Roopa
Oji Mmuo, Christiana
Silveyra, Gabriela Romina
Silveyra, Patricia
author Rivera, Lidys
author_facet Rivera, Lidys
Siddaiah, Roopa
Oji Mmuo, Christiana
Silveyra, Gabriela Romina
Silveyra, Patricia
author_role author
author2 Siddaiah, Roopa
Oji Mmuo, Christiana
Silveyra, Gabriela Romina
Silveyra, Patricia
author2_role author
author
author
author
dc.subject.none.fl_str_mv Bronchopulmonary Dysplasia
Pulmonary hypertension
Preterm infants
Biomarkers
topic Bronchopulmonary Dysplasia
Pulmonary hypertension
Preterm infants
Biomarkers
purl_subject.fl_str_mv https://purl.org/becyt/ford/1.6
https://purl.org/becyt/ford/1
dc.description.none.fl_txt_mv Bronchopulmonary dysplasia (BPD) is a chronic inflammatory lung disease of very-low-birth-weight (VLBW) preterm infants, associated with arrested lung development and a need for supplemental oxygen. Over the past few decades, the incidence of BPD has significantly raised as a result of improved survival of VLBW infants requiring mechanical ventilation. While early disease detection is critical to prevent chronic lung remodeling and complications later in life, BPD is often difficult to diagnose and prevent due to the lack of good biomarkers for identification of infants at risk, and overlapping symptoms with other diseases, such as pulmonary hypertension (PH). Due to the current lack of effective treatment available for BPD and PH, research is currently focused on primary prevention strategies, and identification of biomarkers for early diagnosis, that could also represent potential therapeutic targets. In addition, novel histopathological, biochemical, and molecular factors have been identified in the lung tissue and in biological fluids of BPD and PH patients that could associate with the disease phenotype. In this review, we provide an overview of biomarkers for pediatric BPD and PH that have been identified in clinical studies using various biological fluids. We also present a brief summary of the information available on current strategies and guidelines to prevent and diagnose BPD and PH, as well as their pathophysiology, risk factors, and experimental therapies currently available.
Fil: Rivera, Lidys. State University of Pennsylvania; Estados Unidos
Fil: Siddaiah, Roopa. State University of Pennsylvania; Estados Unidos
Fil: Oji Mmuo, Christiana. State University of Pennsylvania; Estados Unidos
Fil: Silveyra, Gabriela Romina. State University of Pennsylvania; Estados Unidos. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Ciudad Universitaria. Instituto de Biodiversidad y Biología Experimental y Aplicada. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales. Instituto de Biodiversidad y Biología Experimental y Aplicada; Argentina
Fil: Silveyra, Patricia. State University of Pennsylvania; Estados Unidos. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Biología y Medicina Experimental. Fundación de Instituto de Biología y Medicina Experimental. Instituto de Biología y Medicina Experimental; Argentina
description Bronchopulmonary dysplasia (BPD) is a chronic inflammatory lung disease of very-low-birth-weight (VLBW) preterm infants, associated with arrested lung development and a need for supplemental oxygen. Over the past few decades, the incidence of BPD has significantly raised as a result of improved survival of VLBW infants requiring mechanical ventilation. While early disease detection is critical to prevent chronic lung remodeling and complications later in life, BPD is often difficult to diagnose and prevent due to the lack of good biomarkers for identification of infants at risk, and overlapping symptoms with other diseases, such as pulmonary hypertension (PH). Due to the current lack of effective treatment available for BPD and PH, research is currently focused on primary prevention strategies, and identification of biomarkers for early diagnosis, that could also represent potential therapeutic targets. In addition, novel histopathological, biochemical, and molecular factors have been identified in the lung tissue and in biological fluids of BPD and PH patients that could associate with the disease phenotype. In this review, we provide an overview of biomarkers for pediatric BPD and PH that have been identified in clinical studies using various biological fluids. We also present a brief summary of the information available on current strategies and guidelines to prevent and diagnose BPD and PH, as well as their pathophysiology, risk factors, and experimental therapies currently available.
publishDate 2016
dc.date.none.fl_str_mv 2016-03
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
http://purl.org/coar/resource_type/c_6501
info:ar-repo/semantics/articulo
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv http://hdl.handle.net/11336/60769
Rivera, Lidys; Siddaiah, Roopa; Oji Mmuo, Christiana; Silveyra, Gabriela Romina; Silveyra, Patricia; Biomarkers for Bronchopulmonary Dysplasia in the Preterm Infant; Frontiers Media S.A.; Frontiers in Pediatrics; 4; 3-2016; 1-17
2296-2360
2296-2360
CONICET Digital
CONICET
url http://hdl.handle.net/11336/60769
identifier_str_mv Rivera, Lidys; Siddaiah, Roopa; Oji Mmuo, Christiana; Silveyra, Gabriela Romina; Silveyra, Patricia; Biomarkers for Bronchopulmonary Dysplasia in the Preterm Infant; Frontiers Media S.A.; Frontiers in Pediatrics; 4; 3-2016; 1-17
2296-2360
CONICET Digital
CONICET
dc.language.none.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv info:eu-repo/semantics/altIdentifier/url/https://www.frontiersin.org/articles/10.3389/fped.2016.00033/full
info:eu-repo/semantics/altIdentifier/doi/10.3389/fped.2016.00033
dc.rights.none.fl_str_mv info:eu-repo/semantics/openAccess
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
eu_rights_str_mv openAccess
rights_invalid_str_mv https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
dc.format.none.fl_str_mv application/pdf
application/pdf
dc.publisher.none.fl_str_mv Frontiers Media S.A.
publisher.none.fl_str_mv Frontiers Media S.A.
dc.source.none.fl_str_mv reponame:CONICET Digital (CONICET)
instname:Consejo Nacional de Investigaciones Científicas y Técnicas
reponame_str CONICET Digital (CONICET)
collection CONICET Digital (CONICET)
instname_str Consejo Nacional de Investigaciones Científicas y Técnicas
repository.name.fl_str_mv CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas
repository.mail.fl_str_mv dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar
_version_ 1844613951450513408
score 13.070432